A Review on Diverse Neurological Disorders Pathophysiology, Molecular Mechanisms, and Therapeutics

Diving into the future of neurodegenerative disorders, A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics presents an unprecedented compilation of knowledge. It embarks on a journey from the roots of mental disorders, through bacterial and fungal invasions, viral attacks, and genetic predispositions, offering a comprehensive understanding of the neurological landscape. Each chapter uncovers the mysteries behind these debilitating conditions, from the pathogenesis of central nervous system tuberculosis to the role of endocannabinoids in rabies infection. This book’s exploration extends to neuroinflammation, axonal pathology, and the intricate interplay of diet, gut microbiomes, and cognitive decline. It leaves no stone unturned in unravelling the complexities of neurodegeneration, offering a glimmer of hope through probiotics and natural bioactive compounds in preventing diseases like Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). With meticulous discussions on vitamins, micronutrients, antioxidants, and nutraceuticals, this book provides a roadmap for neuroprotection. ‘Neurological Disorders and Neurodegeneration’ is a groundbreaking resource that paves the way for future treatments and innovations, making it an essential read for professionals and enthusiasts alike.

1. Epidemiology and risk factors of mental disorders
2. Bacterial meningitis and neurological disorder
3. An overview on Helminthic brain infections in humans
4. Helminthic infections of the central nervous system
5. Pathogenesis and overview of central nervous system tuberculosis
6. Tuberculosis of central nervous system
7. An overview on tetanus, diphtheria, and diverse bacterial infections of the CNS
8. Tetanus, diphtheria and other bacterial infections of central nervous system
9. Pathogenesis and treatment of syphilis
10. Fungal infection of central nervous system
11. An overview on the fungal infections of the nervous system
12. Acute viral encephalitis, meningitis, and cerebral malaria
13. Neurological complications of COVID-19 infections
14. Genetic addiction risk analysis for “Preaddiction Severity Index” (PAI): A neurobiological behavioral octupus
15. Addressing the role of endocannabinoid system in rabies infection and its potential for modulation
16. Pathogenesis and Treatment of Rabies
17. An overview of pathophysiology and therapeutic approaches of Alzheimer’s disease and Parkinson’s disease
18. Ataxia and motor neuron diseases
19. Multiple system atrophy
20. Progressive supranuclear palsy
21. Epilepsy and Neurodegeneration
22. HIV/AIDS Neurological Disorders
23. Neurodegeneration and Motor Deficits
24. Neurodegeneration in autoimmune central nervous system infection
25. Inflammation and neurodegeneration in multiple sclerosis
26. Autophagy and mitophagy in amyotrophic lateral sclerosis
27. Excitation-inhibition balance in diseases of the brain: Role of NMDA and GABA receptors
28. Nutraceuticals for the prevention of stroke and cerebrovascular injury: An overview
29. HIV infection, type 1 interferons, and immune competence: Correlating brain immunity to neurodegeneration
30. Neuroinflammation: Role of adhesion molecules and signaling networks in neurovascular systems
31. Influence of Axonal Pathology in Traumatic Brain Injury
32. Axonal Pathology in Traumatic Brain Injury: An Overview
33. Ocular neurodegenerative disorders
34. Stress-associated neurodegenerative disorders: A mechanistic exploration
35. Diverse stress and neurodegeneration: An overview
36. Neurodegenerative diseases and circadian rhythm dysfunction: A bidirectional nexus
37. Advancing age, nutraceuticals, and neuroprotection
38. Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults
39. CNS drugs: Classification, characterization, and binding properties towards biomacromolecules
40. The role of gut microbiome in insomnia
41. Novel therapeutics for diverse neurological disorders
42. Elucidating the potential of natural bioactive compounds in neuroprotection
43. Vitamins, micronutrients, antioxidants, and nutraceuticals in neuroprotection: An overview
44. Olive oil and mediterranean diet: The importance of olive oil constituents, and mainly of its polyphenols, in human health - The redox system - Xenohormesis hypothesis
45. Probiotics protect against progressive deterioration of motor functions and Parkinson’s disease
46. Neuroprotective abilities of vitamins, micronutrients, antioxidants, and nutraceuticals
47. Nutraceuticals and Natural Products in the treatment of neurological disorders
48. Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders
49. The Threats and Therapeutics of Neurodegenerative Disorders: A Commentary

• Epidemiology of neurological disorders and pathogenesis.
• Explores neuroinflammation, ligand-receptors binding, and neurodegeneration.
• Discusses aging and associated disorders in the onset of neurological disorders.
• Neuropharmacology and the protective role of bioactive compounds in neuroprotection.